H.B. Fuller Q3 net income beats estimates on pricing actions, restructuring savings

By Reuters News


Overview

  • Adhesives maker's fiscal Q3 revenue rose 5% yr/yr but missed analyst expectations

  • Adjusted EPS for fiscal Q3 rose 21% yr/yr, beating analyst expectations

  • Company says margin gains driven by pricing execution and restructuring savings


Outlook

  • H.B. Fuller expects fiscal 2026 adjusted EBITDA of $655 mln to $670 mln

  • Company sees fiscal 2026 adjusted EPS (diluted) between $4.70 and $4.85

  • H.B. Fuller expects fiscal 2026 cash flow from operations of $300 mln to $325 mln, excluding AMS items


Result Drivers

  • PRICING ACTIONS - Co said pricing increased net revenue by 7.4%, offsetting lower volume and driving organic growth

  • RESTRUCTURING SAVINGS - Co said restructuring efforts contributed to margin improvement and profitability

  • STRATEGIC INVENTORY INVESTMENTS - Co said higher net working capital was driven by inventory investments to support Quantum Leap and supply continuity amid Middle East disruption


Company press release:


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Revenue

Miss

$938.17 mln

$948.19 mln (7 Analysts)

Q3 Adjusted EPS

Beat

$1.52

$1.47 (7 Analysts)

Q3 Adjusted Net Income Attributable

Beat

$83.42 mln

$81.27 mln (6 Analysts)


Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 6 "strong buy" or "buy", 2 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the specialty chemicals peer group is "buy"

  • Wall Street's median 12-month price target for H.B. Fuller Company is $75.00, about 46.9% above its September 22 closing price of $51.07

  • The stock recently traded at 10 times the next 12-month earnings vs. a P/E of 13 three months ago


Reuters Recommended Reads

  • Sept 22 - Evonik to launch second phase of restructuring in 2027, pursues unit sales

  • Sept 22 - UK's Smiths Group FY revenue beats estimates, margin expands


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.